Vanda’s Sleep Drug for the Visually Impaired Gets Positive FDA Appraisal

Drug Industry Daily
A A
FDA reviewers are recommending approval of Vanda’s sleep drug tasimelteon for the visually impaired, overcoming initial disagreements with the company over acceptable primary endpoints.

To View This Article:

Login

Subscribe To Drug Industry Daily